Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.0B | 6.1B | 6.1B | 6.0B |
Cost of revenue | 3.3B | 3.3B | 3.3B | 3.3B |
Gross profit | 2.7B | 2.8B | 2.8B | 2.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | -13M | — | — | -15M |
Other operating expenses | 359M | 281M | 354M | 336M |
Operating income | 2.4B | 2.5B | 2.4B | 2.4B |
Non operating interest income | ||||
Income | — | 52M | 0 | 24M |
Expense | 322M | 312M | 314M | 319M |
Other income expense | 65M | 16M | 87M | 64M |
Pretax income | 2.1B | 2.3B | 2.2B | 2.2B |
Tax provision | 501M | 519M | 518M | 511M |
Net income | 1.6B | 1.8B | 1.7B | 1.7B |
Basic EPS | 2.7 | — | 2.8 | 2.8 |
Diluted EPS | 2.7 | — | 2.8 | 2.7 |
Basic average shares | 601M | — | 607.6M | 609.4M |
Diluted average shares | 601.9M | — | 608.6M | 610.3M |
EBITDA | 3.1B | 3.2B | 3.1B | 3.1B |
Net income from continuing op. | 1.6B | 1.8B | 1.7B | 1.7B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |